Six Month Clinical Trial Assessing Efficacy And Safety Of Inhaled Insulin In Type 1 Diabetes Mellitus.
Status:
Completed
Trial end date:
2000-09-01
Target enrollment:
Participant gender:
Summary
To determine, in subjects with Type 1 Diabetes Mellitus:
1. Whether glycemic control can be achieved at least as effectively with an insulin regimen
involving pre-meal inhaled insulin plus a single bedtime Ultralente injection as with a
conventional subcutaneous insulin regimen involving 2-3 mixed Regular/NPH insulin
injections per day.
2. The toleration and safety of inhaled insulin therapy and its effects after 6 months, if
any, on measures of pulmonary function.